A license to kill.
Fraser
A
A
Imperial Cancer Research Fund Laboratories, London, United Kingdom.
Evan
G
G
D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D017209:Apoptosis / Q000502:physiology*; D029742:Caenorhabditis elegans Proteins; D020170:Caspase 1; D020169:Caspases; D003546:Cysteine Endopeptidases / Q000502:physiology; D015801:Helminth Proteins / Q000502:physiology; D006801:Humans; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D047888:Receptors, Tumor Necrosis Factor, Type I; D015398:Signal Transduction / Q000502:physiology*; D019014:fas Receptor / Q000502:physiology
D015703:Antigens, CD; D029742:Caenorhabditis elegans Proteins; D015801:Helminth Proteins; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D019014:fas Receptor; D020169:Caspases; D003546:Cysteine Endopeptidases; C089223:ced-3 protein, C elegans; D020170:Caspase 1